Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Abacavir + Lamivudine
Kivexa
Routinely available
SMC (175/05)
01/06/2005
Indication
HIV-1
Therapeutic Area
Infections
Status Description
Routinely available
Formulation
600mg/300mg tablets
Comments
June 2005 - Added to the Additional List, for Specialist Use only.
Link to Advice
Advice Published
09/05/2005
SMC Submission Type
Abbreviated
SMC Status
Accepted